Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Benitec Biopharma Limited (BNTC) had Stock-Based Compensation of $5.18M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.96M |
|
-- |
|
-- |
|
$9.80M |
|
$-9.80M |
|
$0.84M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-9.80M |
|
$-9.79M |
|
41.52M |
|
41.52M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$95.08M |
|
$0.12M |
|
$0.95M |
|
$96.03M |
|
$2.02M |
|
$0.40M |
|
$0.40M |
|
$2.43M |
|
$93.60M |
|
$93.60M |
|
$93.60M |
|
26.25M |
|
| Cash Flow Statement Financials | |
$-3.35M |
|
-- |
|
-- |
|
$97.86M |
|
$94.59M |
|
$-3.27M |
|
|
Stock-Based Compensation |
$5.18M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
46.95 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.58% |
|
-9.58% |
|
-9.34% |
|
-9.54% |
|
$3.57 |
|
$-0.08 |
|
$-0.08 |
|